Cerebral Insulin Resistance in Type 2 Diabetes Localized to the Posterior Hypothalamic Nucleus

Overview A research group led by Associate Professor Hideyoshi Kaga, Professor Yoshifumi Tamura, and Professor Hirotaka Watada of the Department of Metabolism and Endocrinology, alongside Associate Professor Takahiro Osada and Professor Kiyotaka Konishi of the Department of Neurophysiology at Juntendo University Graduate School of Medicine, analyzed brain insulin responses in Type 2 diabetes using a combination of high-resolution functional MRI (fMRI) and intranasal insulin administration.

They discovered that while activity in the posterior hypothalamic nucleus rapidly decreased in healthy individuals following insulin administration, this response was absent in patients with Type 2 diabetes. Furthermore, structural MRI analysis of approximately 1,600 community-dwelling elderly individuals confirmed a decrease in gray matter volume in the same region in diabetic patients.

This study suggests that 'cerebral insulin resistance,' previously understood in a generalized sense, may be localized to a specific neural nucleus: the posterior hypothalamic nucleus. This finding is expected to lead to a deeper understanding of diabetes and the exploration of new therapeutic targets. The results were published online in 'JCI Insight' on June 8, 2026.

Key Findings - High-precision identification of cerebral insulin resistance at the hypothalamic nucleus level in Type 2 diabetes. - Discovery that cerebral insulin resistance selectively occurs in the posterior hypothalamic nucleus. - Confirmation of decreased gray matter volume in the posterior hypothalamus via structural MRI analysis of a cohort of approximately 1,600 community-dwelling elderly. - Suggestion that functional brain abnormalities precede structural changes, paving the way for new metabolic intervention research targeting the brain.

Background In Type 2 diabetes, insulin resistance in peripheral tissues is the primary pathology. However, insulin action in the brain—specifically the hypothalamus—has recently been recognized as crucial for maintaining appetite and glucose homeostasis. Previous brain imaging studies often evaluated the hypothalamus as a single region, leaving it unclear which specific neural nuclei were impaired.

Methodology The study involved two analyses: functional assessment (Study 1) and structural assessment (Study 2).

In Study 1, 41 Japanese men were evaluated for brain insulin response using fMRI with intranasal insulin. The healthy group showed rapid signal reduction in the posterior hypothalamic nucleus, while this response was absent in the Type 2 diabetes group.

In Study 2, brain MRI data from 1,609 elderly participants in the Bunkyo Health Study were analyzed. The diabetes group showed a significant decrease in gray matter volume, particularly in the posterior hypothalamus.